352 Final Results of the First in Man Trial of MK4827, a Poly (ADP-ribose) Polymerase (PARP) Inhibitor with Antitumor Activity in BRCA Carriers and Sporadic Cancer Patients
Sandhu, S.K, Wilding, G, Schelman, W.R, Omlin, A, Kreischer, N, Carpenter, C, Iannone, R, Kaye, S, de-Bono, J.S, Wenham, R.M
Published in European journal of cancer (1990) (01.11.2012)
Published in European journal of cancer (1990) (01.11.2012)
Get full text
Journal Article
362 First in human trial of a poly(ADP)-ribose polymerase (PARP) inhibitor MK-4827 in advanced cancer patients (p) with antitumor activity in BRCA-deficient and sporadic ovarian cancers
Wenham, R.M, Sandhu, S.K, Wilding, G, Sun, L, Toniatti, C, Stroh, M, Carpenter, C, de-Bono, J, Baird, R, Schelman, W.R
Published in European journal of cancer supplements (2010)
Published in European journal of cancer supplements (2010)
Get full text
Journal Article
458P Phase (Ph) I/Ib trial of fruquintinib (fru) in patients (pts) with advanced solid tumors: Preliminary results of the dose expansion (exp) cohort in refractory metastatic colorectal cancer (mCRC)
Dasari, N.A., Wang-Gillam, A., Hubbard, J.M., Fernandez, A., Nanda, S., Kania, M., Schelman, W.R., Bekaii-Saab, T.S.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
O-0008 Phase II Study of Gemcitabine + TH-302 vs Gemcitabine Alone in Patients with Locally Advanced and Metastatic Pancreatic Cancer
Ryan, D., Reddy, S., Bahary, N., Uronis, H., Sigal, D.S., Cohn, Allen, Schelman, W.R., Chiorean, E.G., Rosen, P.J., Ulrich, B., Dragovich, T., Del Prete, S., Rarick, M., Eng, C., Kroll, S.
Published in Annals of oncology (01.06.2012)
Published in Annals of oncology (01.06.2012)
Get full text
Journal Article